Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Judith Usall

6PUBLICATIONS

52CO-AUTHORS

PharmacogenomicsSpeech pathologySocial psychologySensory processes, perception and performanceScreen and media culture

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 18, 2025

The DEPRE'5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment.

Víctor Pérez, Dolors Puigdemont, Javier de Diego-Adeliño

|May 15, 2025

Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study.

Jussi Seppälä, Eva Grasa, Anna Alonso-Solis

|Jun 30, 2023

m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study.

Eva Grasa, Jussi Seppälä, Anna Alonso-Solis

|Dec 28, 2020

Cognitive functioning in first episode psychosis. Gender differences and relation with clinical variables.

Regina Vila-Badia, Núria Del Cacho, Anna Butjosa

|Nov 21, 2019

Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.

S Mas, P Gassó, N Rodríguez

|Sep 30, 2016

Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study.

Elena Huerta-Ramos, Maria Soledad Escobar-Villegas, Katya Rubinstein

Pageof 1

Frequent Collaborators

4 joint publications

Susana Ochoa

3 joint publications

Iluminada Corripio

3 joint publications

Katya Rubinstein

3 joint publications

Zsolt Unoka

3 joint publications

Eva Grasa

3 joint publications

Jussi Seppälä

3 joint publications

Jesus Berdun

3 joint publications

Asaf Caspi

2 joint publications

Anna Alonso-Solis

2 joint publications

Erika Jääskeläinen

Frequent Collaborators

4 joint publications

Susana Ochoa

3 joint publications

Iluminada Corripio

3 joint publications

Katya Rubinstein

3 joint publications

Zsolt Unoka

Top Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on : Aug 11, 2015

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

See more related videos

Top Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on : Aug 11, 2015

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

See more related videos